BDF Gestion Sells 2,685 Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC)

BDF Gestion lessened its stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 11.5% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 20,669 shares of the company’s stock after selling 2,685 shares during the period. BDF Gestion’s holdings in GE HealthCare Technologies were worth $1,616,000 at the end of the most recent reporting period.

A number of other large investors have also added to or reduced their stakes in GEHC. LGT Financial Advisors LLC increased its position in shares of GE HealthCare Technologies by 1,673.3% during the third quarter. LGT Financial Advisors LLC now owns 266 shares of the company’s stock valued at $25,000 after acquiring an additional 251 shares in the last quarter. Ashton Thomas Securities LLC bought a new stake in shares of GE HealthCare Technologies in the 3rd quarter worth $26,000. Capital Performance Advisors LLP purchased a new position in shares of GE HealthCare Technologies in the third quarter worth $26,000. Darwin Wealth Management LLC bought a new position in shares of GE HealthCare Technologies during the third quarter valued at $31,000. Finally, Continuum Advisory LLC boosted its position in shares of GE HealthCare Technologies by 101.8% during the third quarter. Continuum Advisory LLC now owns 333 shares of the company’s stock valued at $31,000 after buying an additional 168 shares during the last quarter. Hedge funds and other institutional investors own 82.06% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities analysts have weighed in on GEHC shares. Wells Fargo & Company boosted their target price on GE HealthCare Technologies from $95.00 to $96.00 and gave the stock an “overweight” rating in a research report on Thursday, October 31st. Jefferies Financial Group upgraded shares of GE HealthCare Technologies from a “hold” rating to a “buy” rating and increased their price objective for the company from $95.00 to $103.00 in a research report on Wednesday, January 8th. One research analyst has rated the stock with a sell rating, four have assigned a hold rating, nine have issued a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, GE HealthCare Technologies presently has a consensus rating of “Moderate Buy” and an average price target of $96.00.

GE HealthCare Technologies Trading Up 1.9 %

Shares of GEHC stock opened at $89.55 on Friday. The company has a debt-to-equity ratio of 1.12, a current ratio of 1.23 and a quick ratio of 0.98. The company has a market cap of $40.91 billion, a price-to-earnings ratio of 24.60, a PEG ratio of 2.88 and a beta of 1.11. GE HealthCare Technologies Inc. has a 1 year low of $72.52 and a 1 year high of $94.55. The firm has a fifty day moving average price of $82.76 and a 200-day moving average price of $84.95.

GE HealthCare Technologies (NASDAQ:GEHC) last released its quarterly earnings results on Wednesday, October 30th. The company reported $1.14 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.06 by $0.08. GE HealthCare Technologies had a return on equity of 25.19% and a net margin of 8.56%. The business had revenue of $4.86 billion during the quarter, compared to analyst estimates of $4.87 billion. During the same quarter in the previous year, the company posted $0.99 earnings per share. GE HealthCare Technologies’s revenue for the quarter was up .9% on a year-over-year basis. As a group, equities analysts predict that GE HealthCare Technologies Inc. will post 4.3 earnings per share for the current year.

GE HealthCare Technologies Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 14th will be paid a dividend of $0.035 per share. The ex-dividend date is Tuesday, January 14th. This is an increase from GE HealthCare Technologies’s previous quarterly dividend of $0.03. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.16%. GE HealthCare Technologies’s payout ratio is 3.85%.

Insider Buying and Selling

In related news, CEO Roland Rott sold 3,577 shares of the company’s stock in a transaction on Wednesday, November 6th. The shares were sold at an average price of $86.48, for a total value of $309,338.96. Following the completion of the transaction, the chief executive officer now owns 24,298 shares of the company’s stock, valued at approximately $2,101,291.04. This represents a 12.83 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. 0.27% of the stock is currently owned by insiders.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.